I was going over the 10K and read that l:TC also has to pay all of these fees.
1.LTC must pay a mgt.fee of $200k on the date of the filing of the s-1 for the IPO
2.Pay IAW cost of $4oK per month starting 8/1/08 for research and development work till 8/1/09 totalling $488K
3. Pay a $300K fee for FDA clearance of the 510K payable 10/18/08
4.RRepayment of note between the two companies for 8 % annually beginning 8/1/08
5.Payment of 2% gross royalty of manufacturing price triggered by the $220K sales payable 10/18/08
6.Payment of $60K for reimbursement of costs for the Kiev office.
While we do not know to what extent the company has paid for these fees with only $103K in cash on the books in Sept 2008
It appears that based ypon the timelines given that most of these may have been satisfied already except the first item the fee and costs associated with the filing with the s-1 for the IPO
If my guess is correct we are getting very close to having something happen but the slience from DON and company is deafening and this lack of transparency may affect his IPO sales success.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.